Regulatory content
COVID-19
This topic captures regulatory developments issued as a result of the COVID-19 pandemic which are directly impacting C2P topics.
COVID-19
195
Countries Covered
409
Sources in C2P
Content Overview
The rapid spread of COVID-19 has created unprecedented challenges for manufacturers and supply chains globally. This topic covers regulatory developments issued as a result of COVID-19 directly impacting C2P’s core topics, and is available as a complimentary topic to C2P subscribers.
The topic also provides News & Analysis on regulatory developments outside our core topics but which may be of interest to our clients.
Coverage Included
Our regulatory content in C2P is historically comprehensive with a robust QA process to ensure quality, consistency and accuracy. Below is a high level summary of our coverage for this topic:
- Brazil: Approval of Extraordinary Measures for Carrying Out Conformity Assessment Activities in Countries Affected by the Coronavirus (COVID-19), Portaria No.79, 2020
- Deferral of entry into force of key legislations,
- Extension of deadlines and time limits for reporting, registering, renewing certificates/ licenses or carrying out inspections of factories, workplaces etc.
- Suspension or temporary authorisation of virtual conformity assessment procedures,
- Occupational health and safety requirements and guidelines for workplaces in the context of Covid-19 (e.g obligation to implement Covid-19 prevention plans, hygiene protocols, procedures for testing/ screening employees, and recording COVID-19 cases to health authorities),
- Temporary environmental enforcement policy during the COVID-19,
- Statements and instructions from Data Protection Authorities,
- Temporary exemptions and authorisation of biocidal products.
- News & Analysis:
- EU Commission: European standards for medical supplies made freely available to facilitate an increase of production
- UK Medicines and Healthcare Products Regulatory Agency (MHRA): Regulatory status of equipment being used to help prevent coronavirus (COVID-19)
- Saudi Arabia extends the validity period for conformity certificates registered in SABER for additional 3 month period in response to COVID-19
- Compliance & Risks: COVID-19 Regulatory Developments – Updates 1-14
Learn more about our Regulatory Coverage
Speak to one of our team today for more information on our regulatory content.
